Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 531 - 540 of 763 studies

Metabolic and Endocrine

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Dose Finding Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D). (SAB-142-201(SAFEGUARD))

Respiratory

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab adjunctive therapy in adult participants with COPD with type 2 inflammation characterized by an eosinophilic phenotype (ENDURA-2)

Cardiovascular

A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. | KINSHIP-DCM (DAN-301 (KINSHIP-DCM))

Congenital disorders

A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects with Deletion- or Nondeletion-type Angelman Syndrome (GTX-102-CL210)

A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients with Primary Sclerosing Cholangitis (WIND-PSC Study) (WIND-PSC)

Metabolic and Endocrine

A Phase 3, Double-Blind, Randomized, Placebo-Controlled study of Baricitinib to delay Stage 3 Type 1 Diabetes in at-risk participants aged ≥1 to <36 years. (BARICADE-DELAY)

Evaluation and simulated pilot deployment of “TrustedMDT-Copilot”: an agentic AI copilot providing decision support to Oncology multidisciplinary team meetings

Musculoskeletal

An Open-label Extension Study to Investigate the Long term Safety, Tolerability, Pharmacokinetics, and Efficacy of WVE N531 in Patients with Duchenne Muscular Dystrophy Who Participated in Another Study of WVE N531 (WVE-N531-002)

DPYD polymorphisms in patients with solid tumours receiving fluoropyrimidines: A UK clinical registry

Infection Reproductive health and childbirth

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants (C1091009)